Evaluation of outcome and prognostic factors for dogs living greater than one year after diagnosis of osteosarcoma: 90 cases (1997-2008)

被引:33
作者
Culp, William T. N. [1 ]
Olea-Popelka, Francisco [2 ]
Sefton, Jennifer [2 ]
Aldridge, Charles F. [3 ]
Withrow, Stephen J. [2 ]
Lafferty, Mary H. [2 ]
Rebhun, Robert B. [1 ]
Kent, Michael S. [1 ]
Ehrhart, Nicole [2 ]
机构
[1] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA
[2] Colorado State Univ, Dept Clin Sci, Coll Vet Med & Biomed Sci, Ft Collins, CO 80523 USA
[3] Auburn Univ, Coll Vet Med, Dept Clin Sci, Auburn, AL 36849 USA
来源
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION | 2014年 / 245卷 / 10期
关键词
LIMB-SPARING SURGERY; CANINE APPENDICULAR OSTEOSARCOMA; ALKALINE-PHOSPHATASE ACTIVITY; DISTAL RADIAL OSTEOSARCOMA; PALLIATIVE RADIOTHERAPY; SALVAGE SURGERY; BONE TRANSPORT; AMPUTATION; CHEMOTHERAPY; DOXORUBICIN;
D O I
10.2460/javma.245.10.1141
中图分类号
S85 [动物医学(兽医学)];
学科分类号
090604 [动物药学];
摘要
Objective-To evaluate clinical characteristics, outcome, and prognostic variables in a cohort of dogs surviving > 1 year after an initial diagnosis of osteosarcoma. Design-Retrospective case series. Animals-90 client-owned dogs. Procedures-Medical records for an 11-year period from 1997 through 2008 were reviewed, and patients with appendicular osteosarcoma that lived > 1 year after initial histopathologic diagnosis were studied. Variables including signalment, weight, serum alkaline phosphatase activity, tumor location, surgery, and adjuvant therapies were recorded. Median survival times were calculated by means of a Kaplan-Meier survival function. Univariate analysis was conducted to compare the survival function for categorical variables, and the Cox proportional hazard model was used to evaluate the likelihood of death > 1 year after diagnosis on the basis of the selected risk factors. Results-90 dogs met the inclusion criteria; clinical laboratory information was not available in all cases. Median age was 8.2 years (range, 2.7 to 13.3 years), and median weight was 38 kg (83.6 lb; range, 21 to 80 kg [46.2 to 176 lb]). Serum alkaline phosphatase activity was high in 29 of 60 (48%) dogs. The most common tumor location was the distal portion of the radius (54/90 [60%]). Eighty-nine of 90 (99%) dogs underwent surgery, and 78 (87%) received chemotherapy. Overall, 49 of 90 (54%) dogs developed metastatic disease. The median survival time beyond 1 year was 243 days (range, 1 to 1,899 days). Dogs that developed a surgical-site infection after limb-sparing surgery had a significantly improved prognosis > 1 year after osteosarcoma diagnosis, compared with dogs that did not develop infections. Conclusions and Clinical Relevance-Results of the present study indicated that dogs with an initial diagnosis of osteosarcoma that lived > 1 year had a median survival time beyond the initial year of approximately 8 months. As reported previously, the development of a surgical-site infection in dogs undergoing a limb-sparing surgery significantly affected prognosis and warrants further study.
引用
收藏
页码:1141 / 1146
页数:6
相关论文
共 33 条
[1]
Use of alternating administration of carboplatin and doxorubicin in dogs with microscopic metastases after amputation for appendicular osteosarcoma: 50 cases (1999-2006) [J].
Bacon, Nicholas J. ;
Ehrhart, Nicole R. ;
Dernell, William S. ;
Lafferty, Mary ;
Withrow, Stephen J. .
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2008, 232 (10) :1504-1510
[2]
BERG J, 1992, J AM VET MED ASSOC, V200, P2005
[3]
Prognostic factors in canine appendicular osteosarcoma - a meta-analysis [J].
Boerman, Ilse ;
Selvarajah, Gayathri T. ;
Nielen, Mirjam ;
Kirpensteijn, Jolle .
BMC VETERINARY RESEARCH, 2012, 8
[4]
Evaluation of survival time in dogs with stage III osteosarcoma that undergo treatment: 90 cases (1985-2004) [J].
Boston, SE ;
Ehrhart, NP ;
Dernell, WS ;
Lafferty, M ;
Withrow, SJ .
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2006, 228 (12) :1905-1908
[5]
Toxicity and efficacy of cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma [J].
Chun, R ;
Garrett, LD ;
Henry, C ;
Wall, M ;
Smith, A ;
Azene, NM .
JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION, 2005, 41 (06) :382-387
[6]
Update on the biology and management of canine osteosarcoma [J].
Chun, R ;
de Lorimier, LP .
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 2003, 33 (03) :491-+
[7]
Ehrhart N, 1998, J AM VET MED ASSOC, V213, P1002
[8]
Longitudinal bone transport for treatment of primary bone tumors in dogs: Technique description and outcome in 9 dogs [J].
Ehrhart, N .
VETERINARY SURGERY, 2005, 34 (01) :24-34
[9]
Stereotactic radiosurgery for treatment of osteosarcomas involving the distal portions of the limbs in dogs [J].
Farese, JP ;
Milner, R ;
Thompson, MS ;
Lester, N ;
Cooke, K ;
Fox, L ;
Hester, J ;
Bova, FJ .
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2004, 225 (10) :1567-+
[10]
Garzotto CK, 2000, J VET INTERN MED, V14, P587, DOI 10.1892/0891-6640(2000)014<0587:PSOSAP>2.3.CO